Alejandro Gutierrez-Aranda
San Pedro Garza Garcia, NLE 66260, Mexico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Immunohistochemistry-based molecular subtypes and stromal tumor-infiltrating lymphocytes in triple-negative breast cancer: a chemotherapy-only cohort.
Journal: The oncologist
Published: April 24, 2026
Trop-2 expression is associated with poor survival in pleural mesothelioma.
Journal: Frontiers in oncology
Published: March 28, 2026
Preferences in Cyclin-Dependent Kinase 4/6 Inhibitors for Advanced Breast Cancer Among Medical Oncologists in Latin America.
Journal: JCO global oncology
Published: March 19, 2026
Corrigendum to 'Clinical characteristics and survival outcomes of young women with luminal HER2-low and HER2-ultralow breast cancer' [Cancer Research and Treatment Communications 46 (2026) 101112].
Journal: Cancer treatment and research communications
Published: March 10, 2026
Independent Cancer Research in Low- and Middle-Income Countries: Why it matters and how to build it.
Independent Cancer Research in Low- and Middle-Income Countries: Why it matters and how to build it.
Journal: The oncologist
Published: December 21, 2025
Performance of PREMM5, clinical criteria, and immunohistochemistry for MMR proteins in genetic risk assessment of Mexican patients with colorectal cancer.
Journal: PloS one
Published: November 26, 2025
A review of current and emerging therapies in breast cancer: implications for older adults.
Journal: Expert review of clinical pharmacology
Published: October 26, 2025
Genetic cancer risk knowledge among Mexican pathogenic variant carriers.
Journal: Patient education and counseling
Published: August 03, 2025
Clinical characteristics and survival outcomes of young women with luminal HER2-low and HER2-ultralow breast cancer.
Journal: Cancer treatment and research communications
Published: July 29, 2025
Last Updated: 09/26/2026